ES2078954T3 - Cepas bacterianas del genero bifidobacterium que tienen un potencial para induccion de iga. - Google Patents

Cepas bacterianas del genero bifidobacterium que tienen un potencial para induccion de iga.

Info

Publication number
ES2078954T3
ES2078954T3 ES90401072T ES90401072T ES2078954T3 ES 2078954 T3 ES2078954 T3 ES 2078954T3 ES 90401072 T ES90401072 T ES 90401072T ES 90401072 T ES90401072 T ES 90401072T ES 2078954 T3 ES2078954 T3 ES 2078954T3
Authority
ES
Spain
Prior art keywords
iga
potential
strains
present
induction potential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90401072T
Other languages
English (en)
Inventor
Hisako Yasui
Kazuhito Hayakawa
Makoto Ohwaki
Tatsuhiko Kan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of ES2078954T3 publication Critical patent/ES2078954T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL INVENTO ACTUAL ES PARA PROPORCIONAR UN METODO FACIL, RAPIDO, PARA FILTRAR UNA GRAN CANTIDAD DE SUSTANCIAS QUE TIENEN POTENCIAL DE INDUCCION LGA. EL POTENCIAL DE INDUCCION LGA MENCIONADO AQUI, SIGNIFICA EL POTENCIAL PARA ACTIVAR Y MEJORAR LA ACTIVIDAD DE CELULAS DE PRODUCCION LGA PARA PRODUCIR UN LGA DE TIPO SECRETORIO EN RESPUESTA A ANTIGENOS. EL INVENTO ACTUAL ES PARA FACILITAR DEFORMACIONES BACTERIALES DE TIPOS DE BIFIDOBACTERIAS OBTENIDOS MEDIANTE EL METODO DE FILTRADO DE SUSTANCIAS QUE TIENEN POTENCIAL DE INDUCCION LGA. MAS ESPECIFICAMENTE, EL INVENTO ACTUAL ES PARA PROPORCIONAR YIT 4061, YIT 4062 Y YIT 4063. LAS TRES DEFORMACIONES OBTENIDAS POR EL INVENTO ACTUAL TIENEN UN FUERTE POTENCIAL DE INDUCCION LGA. DEBIDO AL HECHO DE QUE LAS DEFORMACIONES DE BIFIDOBACTERIAS SE HAN CONOCIDO NO PARA MOSTRAR CUALQUIER PATOGENICIDAD PARA HUMANOS Y ANIMALES, EL POTENCIAL DE INDUCCION LGA DE LAS TRES DEFORMACIONES SE PUEDE CONSIDERAR QUE ES UNA DE LAS ACCIONES AUXILIARES, COMO ESTIMULACION NO ESPECIFICA DE CELULAS DE PRODUCCION DE ANTICUERPOS, PARA PROCESAR ANTIGENOS MAS EFECTIVAMENTE, JUNTO CON LA ANTIGENICIDAD COMO CUERPOS EXTRAÑOS DE ELLOS MISMOS.
ES90401072T 1989-04-21 1990-04-20 Cepas bacterianas del genero bifidobacterium que tienen un potencial para induccion de iga. Expired - Lifetime ES2078954T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1100282A JPH07106142B2 (ja) 1989-04-21 1989-04-21 ＩｇＡ誘導能を有するビフィドバクテリウム・ロンガム又はビフィドバクテリウム・ブレーベ

Publications (1)

Publication Number Publication Date
ES2078954T3 true ES2078954T3 (es) 1996-01-01

Family

ID=14269841

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90401072T Expired - Lifetime ES2078954T3 (es) 1989-04-21 1990-04-20 Cepas bacterianas del genero bifidobacterium que tienen un potencial para induccion de iga.

Country Status (12)

Country Link
US (1) US5192685A (es)
EP (1) EP0394136B1 (es)
JP (1) JPH07106142B2 (es)
KR (1) KR0170374B1 (es)
AT (1) ATE130101T1 (es)
AU (1) AU643683B2 (es)
CA (1) CA2014826C (es)
DE (1) DE69023384T2 (es)
DK (1) DK0394136T3 (es)
ES (1) ES2078954T3 (es)
GR (1) GR3018695T3 (es)
NZ (1) NZ233365A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
JPH0827011A (ja) * 1994-07-12 1996-01-30 Yakult Honsha Co Ltd 胎児定着増強剤及び母動物用食
TW357191B (en) * 1996-06-04 1999-05-01 Food Industry Development Res Institute Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method the invention relates to bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method
US6306638B1 (en) 1996-10-22 2001-10-23 Food Industry Research And Development Institute Mutant bifidobacteria strains with acid, bile salt and oxygen tolerance
US6146411A (en) * 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
CN101151041B (zh) * 2005-02-02 2012-12-05 株式会社明治 免疫刺激用组合物
JP2006298783A (ja) * 2005-04-18 2006-11-02 Nisshin Sugar Mfg Co Ltd 免疫賦活組成物
EP1723965A1 (en) 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
KR20090092315A (ko) 2006-12-21 2009-08-31 칼피스가부시키가이샤 ＩｇＡ 생산 촉진제
JP5936392B2 (ja) 2012-03-02 2016-06-22 松谷化学工業株式会社 ＩｇＡ産生促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3120505C2 (de) * 1981-05-22 1986-04-24 EVOG - Etablissement für Verwaltung und Organisation, Balzers Verfahren zum Herstellen von stichfesten Sauermilchprodukten
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
JPS59135883A (ja) * 1983-01-23 1984-08-04 Yakult Honsha Co Ltd ビフイドバクテリウム属の細菌のプロトプラスト調製方法
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤

Also Published As

Publication number Publication date
DE69023384D1 (de) 1995-12-14
JPH07106142B2 (ja) 1995-11-15
GR3018695T3 (en) 1996-04-30
DK0394136T3 (da) 1996-01-02
ATE130101T1 (de) 1995-11-15
KR0170374B1 (ko) 1999-02-01
US5192685A (en) 1993-03-09
AU643683B2 (en) 1993-11-25
EP0394136A2 (en) 1990-10-24
EP0394136B1 (en) 1995-11-08
DE69023384T2 (de) 1996-04-25
AU5372890A (en) 1990-10-25
CA2014826A1 (en) 1990-10-21
CA2014826C (en) 1999-06-15
NZ233365A (en) 1992-09-25
EP0394136A3 (en) 1992-10-07
KR900016470A (ko) 1990-11-13
JPH02280059A (ja) 1990-11-16

Similar Documents

Publication Publication Date Title
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
ES2078954T3 (es) Cepas bacterianas del genero bifidobacterium que tienen un potencial para induccion de iga.
ATE13741T1 (de) Ein spezifisches antigen enthaltender impfkomplex und ihn enthaltender impfstoff.
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
DE69133042D1 (de) Lyophilisierte zubereitung sowie deren herstellung
ATE43500T1 (de) Herstellung von antikoerpern.
ES2088431T3 (es) Preparacion biologica y su utilizacion.
AR241545A1 (es) Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
FR2513122B1 (es)
NL930117I1 (nl) Samenstelling voor verbeterde adsorptie van verschillende kationen
ATE137282T1 (de) Durch klebeverbindungen hergestellte wassergewinnungselemente und deren verwendung
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
ITRM930818A0 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
FI863677A0 (fi) Polydispersa nativa pseudomonas-flagella(h)-antigener (fag) samt foerfarande foer framstaellning daerav.
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
FR2531863B1 (fr) Procede de preparation d'une substance ayant une activite carcinostatique et immunostimulante, a partir de micro-organismes du genre fusobacterium
GB2093347B (en) Immunostimulant material tf-2 from fusobacterium sp
ES2129047T3 (es) Metodo para mejorar la memoria y la calidad de vida.
EP0314993A3 (de) 1,7,9,15-Tetraoxa-4,12-diaza-8-silaspiro-[7.7]-pentadecane, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3872437D1 (de) Verfahren zur gewinnung von insektenpathogenen proteinen und mikroorganismen des typs bacillus thuringiensis.
EP0345559A3 (en) Hiv-2 variants
YOSHII et al. STUDIES ON THIAMINASE OF THE CLOSTRIDIUM II. DISTRIBUTION OF THIAMINASE I AMONG CLOSTRIDIA
吉井善作 et al. STUDIES ON THIAMINASE OF THE CLOSTRIDIUM

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 394136

Country of ref document: ES